More Than Just Blood in the Urine: Recognizing and Treating IgA Nephropathy

TARGET AUDIENCE:
This activity has been designed to meet the educational needs of nephrologists and primary care physicians.
PROGRAM OVERVIEW:
This activity will review the diagnosis and treatment of immunoglobulin A nephropathy (IgAN), citing the latest evidence from care guidelines and clinical trials, and highlighting the importance of kidney biopsy for early diagnosis and treatment. This activity will also discuss the role of proteinuria in kidney disease progression and current and emerging therapies for lowering proteinuria in patients with IgAN to enable clinicians to optimize proteinuria lowering in clinical practice and improve patient care and outcomes.
LEARNING OBJECTIVES:
After participating in the activity, learners should be better able to:
• DISCUSS the etiology and pathophysiology of IgAN
• EXPLAIN the role of proteinuria in IgAN and the importance of early treatment initiation
• REVIEW current treatment guidelines for IgAN and evidence-based strategies for lowering proteinuria
• COMPARE new and emerging therapies for IgAN and their roles in the changing treatment landscape